Skip to main content
IVVD logo

IVVD · Invivyd, Inc.

$0.68 0.00 (-0.44%) At close · Jul 21
Market Cap
$189.23M
Shares
294.61M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$53.43M +110.5%
FY2025 Revenue FY2023–FY2025
Net Income
-$52.49M +69.1%
FY2025 Net Income FY2021–FY2025
Operating Margin
-103.99% +592.8pp
FY2025 Operating Margin FY2024–FY2025
Diluted EPS
-$0.30 +79%
FY2025 Diluted EPS FY2021–FY2025
Operating Cash Flow
-$58.14M +65.9%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021
$55.87M $53.43M $25.38M $0
$58.4M $38.31M $137.25M $158.66M $179.21M $182.89M
$75.3M $66.93M $63.39M $49.13M $47.04M $36.52M
$108.99M $202.26M $212.76M $248.03M $226.91M
$137.64M $108.99M $202.26M $212.76M
-$81.77M -$55.56M -$176.88M -$212.76M -$248.03M -$226.91M
-103.99% -696.8%
$4.17M $3.07M $6.95M $14.12M $6.71M $118K
$0 $0 $0 $0 $0 $0
-$77.6M -$52.49M -$169.93M -$198.64M -$241.32M -$226.79M
-98.25% -669.42%
-$77.62M -$52.53M -$169.92M -$198.38M -$241.58M -$226.8M
USD/shares -$0.30 -$1.43 -$1.81 -$2.23 -$5.32
USD/shares -$0.30 -$1.43 -$1.81 -$2.23 -$5.32
shares 172.21M 118.56M 109.53M 108.27M 42.62M
shares 172.21M 118.56M 109.53M 108.27M 42.62M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2024: $5000 in buybacks.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Biotechnology median 8.68×
EV/EBIT
Biotechnology median 26.56×
P/E (TTM)
Biotechnology median 7.21×

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2025 FY2024 FY2023
Product $53,426,000 $25,384,000 $0
Key facts CIK 1832038 CUSIP 00534A102 13F (30d) 3 filings 3 filers Visit website Investor relations